Fact CheckerSign in

NCT06856720Enrolling by invitation

NMES, Exercise, and Glycemic Control in Older Adults With Type 2 Diabetes

Neuromuscular Electrical Stimulation Versus Combined Aerobic and Resistance Exercise Versus Health Literacy Intervention for Glycemic Control in Institutionalized Older Adults With Type 2 Diabetes: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 10 Aug 2026

Brief summary (registry, in English)

Adults aged 60 years and older with type 2 diabetes living in nursing homes may experience difficulty participating in conventional exercise programs because of frailty, mobility limitations, or chronic health conditions. This randomized controlled trial compares three 12-week non-pharmacological interventions for glycemic management: neuromuscular electrical stimulation (NMES), supervised combined aerobic and resistance exercise, and a structured health literacy intervention. Participants will be randomly assigned to one of the three groups. The primary outcome is weekly mean fasting capillary glucose. Secondary outcomes include health-related quality of life, treatment satisfaction, adherence, and safety. The study aims to identify feasible and clinically relevant strategies for improving diabetes management in institutionalized older adults.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
75 (estimated)
First submitted
26 Feb 2025
Start date
27 Oct 2025
Primary completion date
30 Oct 2026
Lead sponsor
University of Salamanca
NCT number
NCT06856720

What you commit to

  • Study type: Interventional
  • Planned participants: 75
  • From 27 Oct 2025 to the primary completion date, 30 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe cognitive impairment or inability to provide informed consent.
  • Acute or unstable medical condition making participation unsafe.
  • Skin lesions or dermatological conditions preventing safe electrode placement.
  • Any condition judged by the clinical team to preclude safe participation.

Other

  • Contraindications to moderate-intensity exercise.
  • Implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator).

Who the study is looking for

  • Confirmed diagnosis of type 2 diabetes mellitus.
  • Age 60 years or older.
  • Resident in a nursing home or similar long-term care facility in Portugal.
  • Able to understand study procedures and provide informed consent.
  • Stable antidiabetic medication regimen for at least 12 weeks before enrollment.

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nursing Homes and Long-Term Care Facilities in Central Portugal
Coordinator of this site? Confirm its status
ViseuPortugalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.